Search

everythinglearnresearchcommunity

for

Search:↓

PKC ε increases hair follicle stem cell turnover and may raise skin cancer risk.

ZD1839, a cancer drug, can cause mild skin rashes that are treatable without stopping the medication.

A new compound slows cancer cell growth and causes cell death by blocking cell cycle progression and increasing cell-damaging molecules.

JAK inhibitors show promise for treating various skin diseases.

Deleting the MAD2L1 gene in mice led to rapid tumor growth despite chromosomal instability.

CTP-543 is generally safe for treating alopecia areata.

DNCB is highly effective for treating alopecia areata with minimal long-term side effects.

Dacomitinib can cause nail and skin issues, but these can be managed without stopping the drug.

Checkpoint inhibitor therapy can cause skin issues, from mild rashes to severe reactions.

Topical calcitriol-analogs can reduce hair loss caused by chemotherapy.

CS12192 effectively treats alopecia areata with better safety than current options.

The combination of high-dose toremifene and capecitabine was effective for advanced recurrent breast cancer.

Cancer prevention has advanced significantly, with some strategies proving successful.

NCSTN gene mutation causes abnormal skin cell differentiation and more inflammation, contributing to Hidradenitis Suppurativa.

Baricitinib shows promise for treating alopecia areata with mild side effects.

Certain substances can strongly inhibit DNA synthesis in hair cells.

The new chemotherapy combination for advanced lung cancer showed a 35.7% response rate but caused significant side effects.

EGFR-targeting cancer drugs can cause skin rashes and other side effects.

Compound 7p shows strong potential as an anticancer agent.

Compound 4 is a promising treatment for hair loss with low toxicity.

K6 gene expression can be controlled and manipulated in mice for studying skin disorders.

Sorafenib often causes skin side effects, indicating effective cancer treatment.

CI-1033 causes skin lesions in rats, similar to humans, due to EGF receptor inhibition.

Hedgehog pathway inhibitors for advanced basal cell carcinoma can cause side effects, but managing them helps maintain treatment.

Early sunburn treatment with certain inhibitors may reduce skin cancer risk.

JAK inhibitors may become the first approved treatment for alopecia areata if they are proven safe and effective.

Ritlecitinib effectively treats alopecia areata in patients 12 and older with fewer side effects.

Targeting EGFR may help reduce hair loss from chemotherapy.

Targeted cancer therapies often cause serious skin problems that need careful management.